Peter Radice, MD | Authors

TORRANCE MEMORIAL MED CTR PHCY

3330 LOMITA BLVD

Articles

Rationale for Trials Studying Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer

October 01, 1997

Breast cancer is second only to lung cancer as a leading cause of cancer mortality in women. In women with metastatic, hence, essentially incurable disease, we strive to find effective chemotherapeutic regimens that offer a